The aim of this study was to compare two cohorts of LAPC patients treated with SBRT ± CHT vs CRT ± CHT in terms of local control (LC), distant metastases- free survival (DMFS), progression-free survival (PFS), overall survival (OS), and toxicity. Eighty patients were included. Patients in the two cohorts were matched ac- cording to: age ≤/>65 years, tumor diameter (two cut-offs:
Alessandra Arcelli, M.B. (2020). Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case‐control study (PAULA‐1). CANCER MEDICINE, 9, 7879-7887 [10.1002/cam4.3330].
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case‐control study (PAULA‐1)
Alessandra Arcelli;Milly Buwenge;Federica Bertini;Alessandra Guido;Salvatore Parisi;Michele Fiore;Mariacristina Di MarcoInvestigation
;Nicola Simoni;Alessio Giuseppe Morganti
2020
Abstract
The aim of this study was to compare two cohorts of LAPC patients treated with SBRT ± CHT vs CRT ± CHT in terms of local control (LC), distant metastases- free survival (DMFS), progression-free survival (PFS), overall survival (OS), and toxicity. Eighty patients were included. Patients in the two cohorts were matched ac- cording to: age ≤/>65 years, tumor diameter (two cut-offs:File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
articolo di marco 2020 Stereotactic - Cancer Medicine.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
486.52 kB
Formato
Adobe PDF
|
486.52 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
